Dr.sc. Branka Bernard National Contact Point Member of the Programme Committee

Transcription

1 Horizon societal challenge 1 Health, demographic change and wellbeing Work Programme Dr.sc. Branka Bernard National Contact Point Member of the Programme Committee

2 HORIZON 2020 Work Programmes focus on: Merging research problems and existing technologies Joining research processes from development of an innovation to definition of standards and algorithms for its use; Interdisciplinary research covering social and humanistic aspects (gender issues), and international strategies.

3 Health, demographic changes and well-being (2014/2015) Research challenges: Demographic changes, i.e. the ageing of the European population with the need for defining factors related to healthy ageing; Increasing communicable and non-communicable disease burden; Sustainable health and care systems; Development of new drugs; Big studies with big number of data.

4 Research and innovation actions in the personalising health and care Research areas: 1. Understanding health, ageing and disease 2. Effective health promotion, disease prevention, preparedness and screening 3. Improving diagnosis 4. Innovative treatments and technologies 5. Advancing active and healthy ageing 6. Integrated, sustainable, citizen-centred care 7. Improving health information, data exploitation and providing an evidence base for health policies and regulation

5 Health, demographic changes and well-being (Work Programme 2014/2015) This societal challenge includes a strong demand for the integration of ICTs in research processes Topics are defined with: specific challenge scope expected impact

6 Understanding health, ageing and disease PHC ) Understanding health, ageing and disease: determinants, risk factors and pathways public health level research and innovation action: 5 M/54 M/ Two stage PHC ) Understanding diseases: systems medicine - clinical level (from research to clinical practice) PHC ) Understanding common mechanisms of diseases and their relevance in co-morbidities - pathophysiological level (molecular mechanisms, system biology);

7 Effective health promotion, disease prevention, preparedness and screening PHC ) Health promotion and disease prevention: improved inter-sector co-operation for environment and health based interventions PHC ) Health promotion and disease prevention: translating omics into stratified approaches Research and innovation action: 5M/ 24M/ Two stage PHC ) Evaluating existing screening and prevention programmes Research and innovation action: 3M /15M/ Two stage

8 Effective health promotion, disease prevention, preparedness and screening PHC ) Improving the control of infectious epidemics and foodborne outbreaks through rapid identification of pathogens Research and innovation action: M/20 M/Single stage PHC ) Vaccine development for poverty-related and neglected infectious diseases: Tuberculosis Research and innovation action: M/ 25 M/Single stage PHC ) Vaccine development for poverty-related and neglected infectious diseases: HIV/AIDS

9 Improving diagnosis PHC ) Development of new diagnostic tools and technologies: in vitro devices, assays and platforms Research and innovation action: 4-6M/ 48 M/ Two stage PHC ) Development of new diagnostic tools and technologies: in vivo medical imaging technologies PHC and 2015) Clinical validation of biomarkers and/or diagnostic medical devices SME instrument: 1-5 M/ 66 M/ Single stage

10 Innovative treatments and technologies PHC ) New therapies for chronic non-communicable diseases Research and innovation actions: 4-6 M/ 60 M/ Two stage PHC ) New therapies for rare diseases PHC /15) Clinical research on regenerative medicine Research and innovation action: 5M/ 36M/ Single stage

11 Innovative treatments and technologies PHC ) Tools and technologies for advanced therapies PHC ) Comparing the effectiveness of existing healthcare interventions in the elderly Research and innovation action: 5 M/ 48 M/ Two stage PHC ) Establishing effectiveness of health care interventions in the pediatric population

12 Advancing active and healthy ageing PHC ) Advancing active and healthy ageing with ICT: Service robotics within assisted living environments Research and innovation action: 3-4 M/ 24.6 M/ Single stage PHC ) Advancing active and healthy ageing with ICT: ICT solutions for independent living with cognitive impairment Innovation action: 3 M/ 10 M (70%) /Single stage PHC ) Advancing active and healthy ageing with ICT: Early risk detection and intervention PHC ) Promoting mental wellbeing in the ageing population

13 Integrated, sustainable, citizen-centred care PHC ) Developing and comparing new models for safe and efficient, prevention oriented, health and care systems Research and innovation action: 5M/ 30M/ Two stage PHC ) Piloting personalised medicine in health and care systems PHC ) Advanced ICT systems and services for Integrated Care PHC ) Self-management of health and disease: citizen engagement and mhealth Research and innovation action: 5M /60M/ Single stage

14 Integrated, sustainable, citizen-centred care PHC ) Self-management of health and disease and patient empowerment supported by ICT PHC Self-management of health and disease and decisional support systems based on predictive computer modelling used by the patient him or herself PHC ) - Public procurement of innovative ehealth services

15 Improving health information, data exploitation and providing an evidence base for health policies and regulation PHC ) Digital representation of health data to improve diseases' diagnosis and treatment PHC ) Foresight for health policy development and regulation Research and innovation action: 2-3M/ 6 M/ Single stage PHC ) Advancing bioinformatics to meet biomedical and clinical needs Research and innovation action: 2-3M/ 24M/ Two stage

16 Improving health information, data exploitation and providing an evidence base for health policies and regulation PHC ) New approaches to improve predictive human safety testing PHC ) ehealth interoperability Coordination and support action: 1M/ 4M/ Single stage

17 Co-ordination activities HCO ) Support for the European Innovation Partnership on Active and Healthy Ageing Coordination and support actions: 1-2M/ 2M/ Single stage HCO ) Coordination Action for the Joint Programming Initiative (JPI) "More Years, Better Lives - the Challenges and Opportunities of Demographic Change - enhancement of the coordination and collaboration between national research programmes on demographic changes Coordination and support actions: 1-2M/ 2M/ Single stage HCO ) Support for the European reference networks: efficient networks modelling and validation

18 Co-ordination activities HCO ) Support for international infectious disease preparedness research Coordination and support actions: 2-3M/ 3M/ Single stage HCO ) Global Alliance for Chronic Diseases: prevention and treatment of type 2 diabetes - prevention and/or treatment strategies Research and innovation actions: 1-3M/ 9M/ Single stage HCO ) Global Alliance for Chronic Diseases: 2015 priority

19 Co-ordination activities HCO ) ERA-NET: Establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020 ERA-NET Co-fund: 5M/ 5M/ Single stage HCO ) ERA-NET: Aligning national/regional translational cancer research programmes and activities ERA-NET Co-fund: 5M/ 5M/ Single stage HCO ) ERA-NET: Systems medicine to address clinical needs ERA-NET Co-fund: 5M/ 5M/ Single stage

20 Co-ordination activities HCO ) ERA-NET: Rare Diseases research implementing International Rare Diseases Research Consortium objectives ERA-NET Co-fund: 5M/ 5M/ Single stage HCO ) ERA-NET: Collaboration and alignment of national programmes and activities in the area of brain-related diseases and disorders of the nervous system HCO ) ERA-NET: Antimicrobial Resistance HCO ) ERA-NET: Cardiovascular disease

21 Co-ordination activities HCO ) Bridging the divide in European health research and innovation Coordination and support actions: 0,5M/ 1M/ Single stage HCO ) Mobilisation and mutual learning action plan Coordination and support actions: 1M/ 1M/ Single stage

22 Support actions HOA /2015) Subscription fee: Human Frontier Science Programme Organisation Subscription: 4.765M HOA /2015) Tenders for programme evaluation, studies and impact assessment and for conferences, events and outreach activities Public procurement: 4.7M HOA /2015) Presidency events- ehealth (organisation of the conference) Grant to identified beneficiary- Coordination and support actions: EUR

23 Support actions HOA /2015) Independent experts assisting in proposal evaluations and project reviews Expert contracts: 7.83M HOA ) Grant to the Global Allience for Chronic Diseases Grant to identified beneficiary- Coordination and support actions: EUR HOA ) National Contact Points Coordination and support actions: 2M EUR

24 Support actions HOA ) Stem cell research outreach Grant to identified beneficiary- Coordination and support actions: EUR HOA ) ehealth Sectoral Inducement Prize Inducement prize: 1M EUR HOA ) Inducement Prize Inducement prize: 1M EUR

25 Health, demographic changes and well-being (2014/2015) Publication date: Deadlines in 2014: (stage one of two stage calls) (single stage calls) (stage two of two stage call)

26 Health, demographic changes and well-being (2014/2015) PHC /2015 Opening date: Deadlines in 2014: Phase 1: ; ; Phase 2: ; ;

27 Tema zdravlje u drugim radnim programima Obzora 2020.

28 Teme zdravlja u drugim radnim programima NMK : Biomaterials for treatment and prevention of Alzheimer s disease Develop new multifunctional biomaterials, as part of eventual medical devices and advanced therapies, which aim to create, optimise, enhance, substitute or support therapeutic interventions in Alzheimer s disease, such sd: materials and devices for early detection and advanced diagnostics, biocompatible and biodegradable biomaterials as part of minimally invasive treatments, smart bioactive and biocompatible materials with improved longevity. NMK : Coordination of EU and international efforts in safety of nanotechnology: The main aim is to bring together EU member states and international efforts for risk assessment, management and governance by streamlining data collection and data management on regulatory oriented toxicology testing of nanomaterial, exposure monitoring, LCA, and disposal and treatment of waste nanomaterials.

29 SFS : Assessing the health risks of combined human exposure to multiple food-related toxic substances: The state-of-the-art frameworks already in place at international level should be reviewed in the quest for a harmonised approach. Proposals should focus on the health risks of combined exposures to multiple chemicals from multiple sources across differing life stages, taking into account also the gender dimension relevance. SFS : Proteins of the future : The growing demand for meat and other protein-rich food sources, in many parts of the world, is of increasing concern, environmental sustainability issues and land-use and food security concerns. Optimal production and processing methods, location (EU or other), health effects, environmental impact, and legal issues remain unanswered.

30 SFS : Tackling malnutrition in the elderly: Changes in body composition, organ function, the ability to eat or access food, inadequate dietary intake and the partial loss of taste and smell are associated with ageing and may contribute to malnutrition. Energy challange: LCE /15: Developing the next generation technologies of renewable electricity and heating/cooling: Environment, health and safety issues shall be considered in all developments and appropriately addressed. LCE /2015: Demonstration of renewable electricity and heating/cooling technologies: Environment, health and safety issues shall be considered in all developments and appropriately addressed.

31 Secure societies: Emerging diseases and their pandemic potential pose a great security threat at national and EU level.thirty four percent of all deaths worldwide are now attributable to infectious disease. Improving capacity-building is key to fight epidemics and the European Union must increase its efforts to improve domestic and global risk assessment, surveillance, communication capability and governance. Additionally, reducing disease transmission through public education and related measures is also crucial to minimizing pandemic impacts, i.e. for health security and protection in case of large-scale pandemics, further capacitybuilding is essential.

32 Hvala na pažnji